ResMed (RMD) Tops Q1 EPS by 3c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $228.35 -0.37%
Revenue Growth %: +6.9%
Financial Fact:
Basic earnings per share: 0.54
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +6.9%
Financial Fact:
Basic earnings per share: 0.54
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.64, $0.03 better than the analyst estimate of $1.61. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.1 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
- UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
